Cancidas

Candidemia, Communicable Diseases, Peritonitis + 7 more
Treatment
16 FDA approvals
8 Active Studies for Cancidas

What is Cancidas

CaspofunginThe Generic name of this drug
Treatment SummaryCaspofungin, also known by its brand name Cancidas, is a type of antifungal drug used to treat fungal infections. It is typically administered through an intravenous injection and works by blocking the fungal cell wall from creating β(1,3)-D-Glucan. Caspofungin is most commonly used to treat infections caused by Aspergillus and Candida.
Cancidasis the brand name
image of different drug pills on a surface
Cancidas Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cancidas
Caspofungin
2001
22

Approved as Treatment by the FDA

Caspofungin, also known as Cancidas, is approved by the FDA for 16 uses including Abdominal Abscess and Febrile Neutropenia .
Abdominal Abscess
Febrile Neutropenia
Peritonitis
Invasive Aspergillosis
Febrile Neutropenia
Candidiasis
pleural space infections
Systemic candidiasis
Abscess, Intra-Abdominal
Communicable Diseases
Yeast Infection
Esophageal Candidiasis
Candidemia
Therapeutic procedure
Peritonitis
Neuroaspergillosis

Effectiveness

How Cancidas Affects PatientsCaspofungin is a type of antifungal medication used to treat infections caused by Aspergillus and Candida fungi. It works by preventing the fungi from forming its cell wall, which helps stop the infection from spreading. Although there is a chance that the fungi can become resistant to the drug, there has not been any research showing that this has happened with Caspofungin.
How Cancidas works in the bodyCaspofungin inhibits the formation of beta-(1,3)-D-glucan, a kind of molecule only found in certain fungi. This molecule is necessary for the fungi's cell wall, so blocking its production weakens the cell and helps kill the fungus. The drug targets the enzyme that produces this molecule.

When to interrupt dosage

The proposed portion of Cancidas is contingent upon the diagnosed state, such as Abscess, Intra-Abdominal, Therapeutic procedure and Invasive Aspergillosis. The amount of dosage is contingent upon the method of delivery (e.g. Powder, for solution - Intravenous or Injection, powder, for solution - Intravenous) indicated in the table below.
Condition
Dosage
Administration
Peritonitis
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Candidemia
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Communicable Diseases
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Yeast Infection
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Abdominal Abscess
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Esophageal Candidiasis
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Therapeutic procedure
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Neuroaspergillosis
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Febrile Neutropenia
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous
Oropharyngeal Candidiasis
50.0 mg, 70.0 mg, , 5.0 mg/mL, 7.0 mg/mL
, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous

Warnings

There are 20 known major drug interactions with Cancidas.
Common Cancidas Drug Interactions
Drug Name
Risk Level
Description
Revefenacin
Major
Caspofungin may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Acyclovir
Minor
The excretion of Acyclovir can be decreased when combined with Caspofungin.
Adefovir dipivoxil
Minor
The excretion of Adefovir dipivoxil can be decreased when combined with Caspofungin.
Alprostadil
Minor
The excretion of Alprostadil can be decreased when combined with Caspofungin.
Ambrisentan
Minor
The excretion of Ambrisentan can be decreased when combined with Caspofungin.
Cancidas Toxicity & Overdose RiskPotential side effects of the drug include rash, swelling, and rarely, nausea.

Cancidas Novel Uses: Which Conditions Have a Clinical Trial Featuring Cancidas?

17 active trials are currently in process to investigate the potential of Cancidas in managing Peritonitis, Invasive Aspergillosis and Esophageal Candidiasis.
Condition
Clinical Trials
Trial Phases
Peritonitis
0 Actively Recruiting
Therapeutic procedure
0 Actively Recruiting
Yeast Infection
0 Actively Recruiting
Abdominal Abscess
0 Actively Recruiting
Neuroaspergillosis
0 Actively Recruiting
Febrile Neutropenia
3 Actively Recruiting
Phase 2, Not Applicable
Esophageal Candidiasis
0 Actively Recruiting
Communicable Diseases
2 Actively Recruiting
Not Applicable
Candidemia
3 Actively Recruiting
Phase 3, Phase 2
Oropharyngeal Candidiasis
0 Actively Recruiting

Cancidas Reviews: What are patients saying about Cancidas?

4.7Patient Review
10/22/2010
Cancidas for Fungal Infection of the Esophagus
I was able to effectively treat my wife's yeast infection with this medication. The short shelf life is really the only downside, but other than that it wasn't any worse than any other medication she's taken.
3.7Patient Review
11/22/2008
Cancidas for Aggressive Fungal Infection - Invasive Aspergillosis
I was in and out of the hospital for six months with a really serious case of aspergillosis. This medicine saved my life with very few side effects, which is saying a lot considering I was also dealing with tuberculosis and pneumocystis at the time.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about cancidas

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Cancidas used for?

"Cancidas is a medication used to treat fungal infections in the stomach, lungs, esophagus, or other internal body areas. It may be used alone or with other medications."

Answered by AI

What is caspofungin used for?

"Caspofungin is used to treat serious fungal infections, including candidemia, esophageal candidiasis, other candida infections, and aspergillosis."

Answered by AI

Is caspofungin an antibiotic?

"Caspofungin acetate is an antifungal antibiotic that inhibits the growth of fungi by preventing the synthesis of 1,3-β-d-glucan, an essential component of the fungal cell wall. While caspofungin is effective against yeasts and dimorphic fungi such as Candida albicans, its effect on Aspergillus fumigatus is less well understood."

Answered by AI

What is micafungin used to treat?

"Micafungin is an antifungal medication used to treat serious fungal infections such as candidemia, acute disseminated candidiasis, candida peritonitis, and esophageal candidiasis."

Answered by AI

Clinical Trials for Cancidas

Have you considered Cancidas clinical trials? We made a collection of clinical trials featuring Cancidas, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top